Todd Engel, 63, says Ozempic cost him the sight in both eyes, and he is suing Novo Nordisk for failing to warn him. Europe's regulator lists the eye condition NAION as a
Novo Nordisk CEO Mike Doustdar set a five-blockbuster target by 2030 and unveiled a $149 weight-loss pill at Monday's capital markets day — even as rivals Viking Therapeutics, Structure Therapeutics, and Altimmune
The AI pioneer who built the leading alternative to large language models joins Cellular Intelligence's advisory board alongside Moderna co-founder Bob Langer, as the company's DeltaStem foundation model moves toward clinical application
Merck posted a GAAP net loss of $1.34 billion in Q2 2026, but the number was accounting, not collapse — a $5.7 billion one-time charge from the Terns acquisition masked revenue of
Sun Pharma posted ₹2,895 crore profit (+27%) and Lupin set a revenue record in Q1 FY27, while Dr Reddy's profit fell 69% on a ₹240 crore semaglutide API write-down and Cipla's margins
Follow